Veerhealth Care Limited

Veerhealth Care Ltd has announced the closure of its trading window. The specific dates for the closure and reopening are not detailed in this announcement, but it is a standard corporate action typically preceding financial results or other significant corporate events. Shareholders are advised to note this closure.

Veerhealth Care Ltd has issued a corrigendum to the notice of its 34th Annual General Meeting (AGM) and Annual Report for the financial year 2025-26. The correction addresses an inadvertent typographical error regarding the timing of the AGM. The correct time for the AGM, scheduled for September 23, 2026, will be 04:00 p.m. instead of the previously stated 11:30 a.m. All other contents, information, statements, and particulars contained in the original AGM notice and Annual Report remain unchanged. The corrigendum will be available on the company's website and has been submitted to the stock exchange.

Veerhealth Care Limited has received a sample order worth ₹0.07 Lacs for oral care products from a company with an Indo-Canadian joint venture. This client is a major global supplier of luxury amenities to hotels and airlines. A Memorandum of Understanding (MoU) has been signed for a long-term business relationship, with expectations of significantly larger orders in the future. The company anticipates supplying oral care products to the Indian, USA, and Canadian markets through this partnership. Veerhealth Care projects a total income of ₹105 crores with a PAT of ₹5-7 crores in FY 2026-27, and expects an additional turnover of ₹3-4 crores from this client within six months. For FY 2027-28, they forecast a total income of ₹156 crores with a PAT of ₹9-11 crores, including an additional ₹10 crores turnover from this client.

Veerhealth Care Ltd has entered into a supply agreement with an Indo-Canadian joint venture, a major global manufacturer of luxury amenities. This partnership will enable Veerhealth Care to produce and supply oral care products to the Indian, USA, and Canadian markets. The company has already secured its first purchase order for 3,95,000 units of oral care products, valued at ₹10,07,800, to be supplied in tubes and sachets within 45 days. This deal marks a significant step for the company in expanding its market reach.

Veerhealth Care Limited has announced the receipt of a monthly repeat order worth ₹4.36 Crore from a leading Indian FMCG company for the supply of skincare products. This order is expected to be executed within 45 days. The company also provided forward-looking statements, projecting total income of ₹105 crores with PAT of ₹5-6 crores for FY 2026-27, and total income of ₹156 crores with PAT of ₹9-10 crores for FY 2027-28. Veerhealth Care is also in advanced discussions for oral care exports to Russia and finalizing talks with a major hotel amenities supplier. The company highlights its USFDA plant clearance as a distinctive achievement.

Veerhealth Care Ltd has announced receiving a significant order from a major FMCG company for skincare products. The order is valued at Rs. 436.99 Lakhs and is expected to contribute to the company's turnover growth. The order is for the supply of face care products and is to be executed within 45 days. This marks a notable business development for Veerhealth Care, highlighting its capabilities in the skincare segment and its ability to secure contracts with large industry players. The company has confirmed that there are no promoter interests in the awarding entity and the transaction does not fall under related party transactions.

Veerhealth Care Ltd has informed the stock exchange that it has sent a letter to shareholders who have not registered their email addresses, providing a weblink to the Integrated Annual Report for the financial year 2025-2026. The 34th Annual General Meeting is scheduled for September 23, 2026. The company also reminded shareholders to update their KYC details as per SEBI regulations, including PAN, address, mobile number, bank account, and nomination, especially for those holding physical securities. Failure to update KYC may affect dividend and other payments.

Veerhealth Care Ltd. has filed its 34th Annual Report for the financial year 2025-2026, as per SEBI regulations. The report will be available on the company's website. The company has also announced its 34th Annual General Meeting (AGM) to be held on September 23, 2026, via Video Conferencing. Key agenda items include the adoption of audited financial statements for FY 2025-26 and the re-appointment of Mrs. Shruti A. Shah as a Director retiring by rotation. The AGM will be conducted virtually, dispensing with the need for physical attendance and proxy forms.

Veerhealth Care Ltd. has announced its 34th Annual General Meeting (AGM) to be held on September 23, 2026, at 11:30 AM via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also released its Annual Report for the financial year 2025-2026. Key agenda items include the adoption of audited financial statements for the year ended March 31, 2026, and the re-appointment of Mrs. Shruti A. Shah as a Director liable to retire by rotation. The AGM will be conducted virtually in compliance with Ministry of Corporate Affairs (MCA) circulars, dispensing with physical attendance and proxy appointments. The annual report and notice are available on the company's website.

Veerhealth Care Limited announced its Q1FY27 unaudited financial results, showcasing significant year-over-year growth. Total revenues surged by 388.13% to ₹25.09 Crore, EBITDA grew by 233.87% to ₹2.07 Crore, and PAT increased by 412.50% to ₹1.23 Crore. The company also highlighted several key orders, including ₹293 Lakhs for body care products from a New York-based company and ₹1824.40 Lakhs for skincare products from an Indian FMCG major. USFDA clearance for OTC products and advanced discussions for exports to Russia were also noted. Veerhealth Care anticipates total income of ₹105 crores with PAT of ₹5-6 crores in FY26-27 and ₹156 crores with PAT of ₹9-10 crores in FY27-28.